Demonstration of Viable, Stunned Myocardium with Technetium-99m-Sestamibi Page 1
Demonstration of Viable, Stunned Myocardium with Technetium-99m-Sestamibi Jeffrey I …

(2, 5). The common clinical setting in which stunned myocardium is ob served is
thrombobytic therapy or acute revascularization therapy for acute myocardial infarction. By …

15mm the rest study on Day 2, potentially saving diagnostic costs for the patient or third-
partypayers. The disadvantages of the two-day protocol are the un certainty as to when the …

Objective. 99mTc-HL-91 (Prognox) is a potential new hypoxia-avid myocardial imaging
agent. The purpose of this study was to determine whether this tracer would demonstrate …

To evaluate whether a prolonged infusion of Tc-99m sestamibi allows for visualization of
viable myocardium in areas of hypoperfused myocardium, 25 patients were prospectively …

Rest technetium 99m-sestamibi uptake may underestimate myocardial viability in asynergic
territories. Because nitrate administration was reported to improve thallium 201 uptake in …

The noninvasive assessment of myocardial viability in patients with coronary artery disease
and depressed left ventricular function has proven clinically useful for identifying those …

6. Werns SW, Shea Mi, Mitsos SE, Ctal. Reduction of the size ofinfarction by allopurinol in
the ischemic reperfused canine heart. Circulation 1986; 73: 5l8— 524. 7. Rao PS, Lukes ii …

Clinical sestamibi imaging protocols after reperfusion therapy are based on the premise that
redistribution does not occur. However, animal studies that use punch biopsies or imaging …

The relation between radioisotopic and echocardiographic markers of myocardial viability
and postrevascularization recovery of function is still to be defined. To this purpose, 14 …